Myriad Genetics (MYGN) Acquisitions (2011 - 2018)

Myriad Genetics has disclosed Acquisitions across 4 years of filings, most recently posting -$1.1 million for Q4 2018.

• In Q4 2018, Acquisitions changed N/A year-over-year to -$1.1 million; the TTM figure through Dec 2020 stood at -$1.1 million (changed N/A YoY), while the FY2022 annual figure was $57.2 million, changed N/A from the prior year.
• Acquisitions fell to -$1.1 million in Q4 2018, from $279.6 million in the prior quarter.
• Over the last five years, Acquisitions for MYGN reached as high as $279.6 million in Q3 2018 and fell as low as -$1.1 million in Q4 2018.
• The 3-year median for Acquisitions is $3.1 million (2016), against an average of $98.9 million.